unknown
Stage
About
Enlaza Therapeutics develops biologic drugs using its War-LockTM technology, a synthetic biology platform that engineers biologics to irreversibly bind and lock to disease-related targets, aiming to enhance efficacy and safety.
Explore Enlaza Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.